NZ320442A - Solubilisation methods of biologially active material in an amphiphile - Google Patents
Solubilisation methods of biologially active material in an amphiphileInfo
- Publication number
- NZ320442A NZ320442A NZ320442A NZ32044296A NZ320442A NZ 320442 A NZ320442 A NZ 320442A NZ 320442 A NZ320442 A NZ 320442A NZ 32044296 A NZ32044296 A NZ 32044296A NZ 320442 A NZ320442 A NZ 320442A
- Authority
- NZ
- New Zealand
- Prior art keywords
- agent
- amphiphile
- solulan
- medicament
- vials
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521805.3A GB9521805D0 (en) | 1995-10-25 | 1995-10-25 | Solubilisation methods |
| PCT/GB1996/002609 WO1997015289A1 (en) | 1995-10-25 | 1996-10-25 | Solubilisation methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ320442A true NZ320442A (en) | 1999-10-28 |
Family
ID=10782854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ320442A NZ320442A (en) | 1995-10-25 | 1996-10-25 | Solubilisation methods of biologially active material in an amphiphile |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0857061A1 (ja) |
| JP (1) | JP2000502990A (ja) |
| KR (1) | KR19990067028A (ja) |
| CN (1) | CN1202818A (ja) |
| AU (1) | AU704292B2 (ja) |
| BR (1) | BR9611343A (ja) |
| CA (1) | CA2235487A1 (ja) |
| GB (1) | GB9521805D0 (ja) |
| NO (1) | NO981864L (ja) |
| NZ (1) | NZ320442A (ja) |
| WO (1) | WO1997015289A1 (ja) |
| ZA (1) | ZA969016B (ja) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9605709D0 (en) * | 1996-03-19 | 1996-05-22 | Cortecs Ltd | Method |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| ES2351527T3 (es) | 2006-05-30 | 2011-02-07 | Intarcia Therapeutics, Inc | Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración. |
| PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
| AU2008244523B2 (en) | 2007-04-23 | 2012-02-16 | Intarcia Therapeutics, Inc. | Suspension formulations of insulinotropic peptides and uses thereof |
| WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| KR102093612B1 (ko) | 2009-09-28 | 2020-03-26 | 인타르시아 세라퓨틱스 인코포레이티드 | 실질 항정상태 약물 전달의 신속 확립 및/또는 종결 |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| KR20240042548A (ko) | 2015-06-03 | 2024-04-02 | 인타르시아 세라퓨틱스 인코포레이티드 | 임플란트 배치 및 제거 시스템들 |
| TWI814219B (zh) | 2016-05-16 | 2023-09-01 | 美商因塔希亞治療公司 | 升糖素受體選擇性多肽和彼之使用方法 |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| IL267736B2 (en) | 2017-01-03 | 2024-03-01 | Intarcia Therapeutics Inc | Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0012115A1 (de) * | 1978-12-04 | 1980-06-11 | Ciba-Geigy Ag | Pharmazeutische Präparate zur topischen Behandlung von Virusinfektionen |
| US4411882A (en) * | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
-
1995
- 1995-10-25 GB GBGB9521805.3A patent/GB9521805D0/en active Pending
-
1996
- 1996-10-25 NZ NZ320442A patent/NZ320442A/en unknown
- 1996-10-25 JP JP9516406A patent/JP2000502990A/ja active Pending
- 1996-10-25 AU AU73178/96A patent/AU704292B2/en not_active Ceased
- 1996-10-25 EP EP96935083A patent/EP0857061A1/en not_active Withdrawn
- 1996-10-25 BR BR9611343-0A patent/BR9611343A/pt not_active Application Discontinuation
- 1996-10-25 CN CN96198527A patent/CN1202818A/zh active Pending
- 1996-10-25 KR KR1019980702965A patent/KR19990067028A/ko not_active Application Discontinuation
- 1996-10-25 WO PCT/GB1996/002609 patent/WO1997015289A1/en not_active Application Discontinuation
- 1996-10-25 CA CA002235487A patent/CA2235487A1/en not_active Abandoned
- 1996-10-25 ZA ZA9609016A patent/ZA969016B/xx unknown
-
1998
- 1998-04-24 NO NO981864A patent/NO981864L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997015289A1 (en) | 1997-05-01 |
| EP0857061A1 (en) | 1998-08-12 |
| JP2000502990A (ja) | 2000-03-14 |
| BR9611343A (pt) | 1999-12-28 |
| KR19990067028A (ko) | 1999-08-16 |
| NO981864L (no) | 1998-06-24 |
| NO981864D0 (no) | 1998-04-24 |
| ZA969016B (en) | 1998-04-28 |
| CA2235487A1 (en) | 1997-05-01 |
| AU7317896A (en) | 1997-05-15 |
| AU704292B2 (en) | 1999-04-15 |
| GB9521805D0 (en) | 1996-01-03 |
| CN1202818A (zh) | 1998-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU704292B2 (en) | Solubilisation methods | |
| EP0752245B1 (en) | Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery | |
| Wagner et al. | Liposomes produced in a pilot scale: production, purification and efficiency aspects | |
| US7018980B2 (en) | Method for preparation of orally administrated insulin formulation | |
| US6040295A (en) | Formulated nucleic acid compositions and methods of administering the same for gene therapy | |
| Ma et al. | Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying | |
| EP0994727B1 (en) | Process for solubilizing pharmaceutically active ingredients in water and in aqueous vehicles | |
| JP3267611B2 (ja) | リポソーム−ポリエンプレリポソーム粉末とその製造方法 | |
| MXPA04009103A (es) | Preparacion de nanodispersiones estabilizadas, esteriles. | |
| KR20030078740A (ko) | 파클리탁셀을 기본으로 하는 개선된 항종양 조성물 | |
| US5556637A (en) | Water containing liposome system | |
| CN102151250A (zh) | 一种固体脂质纳米粒制备新方法 | |
| JP2007525474A (ja) | ポリオキシエチレン誘導体のナノ粒子 | |
| RU2304430C2 (ru) | Способ получения инъекционной лекарственной формы фосфолипидного препарата "фосфоглив" для лечения и профилактики острых и хронических заболеваний печени | |
| CA2048471C (en) | Water-containing liposome system | |
| EP0857069A1 (en) | Methods of preserving microorganisms | |
| US6165773A (en) | Methods of preserving viruses | |
| US9757337B2 (en) | Multicompartmental lipid nanoparticles | |
| CN108653206B (zh) | 一种黄芩素纳米混悬剂及其制备方法 | |
| EP4098252A1 (en) | Poly amphiphilic complexes for the delivery of a hydrophobic active agent, compositions and methods | |
| KR100433363B1 (ko) | 아시클로버함유 외용필름형성 하이드로겔 제제 | |
| Gregory | Preparation of Liposomes and Oily Formulations by Freeze-Drying of Monophase Solutions | |
| CN117224481A (zh) | 一种食品级的o/w槲皮素微乳及其制备方法和应用 | |
| Li et al. | Preparation of liposomes and oily formulations by freeze-drying of monophase solutions | |
| CN114796511A (zh) | 一种混合型增溶剂及其制备方法 |